Pathogenetic approaches to treating constipations


Cite item

Full Text

Abstract

Constipation affects 15-25% of people. Its mechanisms are various. There are constipations due to intestinal dyskinesia (functional constipation, irritated bowel syndrome), slow transit (colonic inertia), and muscular apparatus discoordination ensuring defecation (dyssynergic defecation). The treatment of different types of constipation uses prokinetics (type 4 serotonin receptor agonists, chlorine channels activators and guanylate cyclase C channel activators) or spasmolytics, among which pinaverium bromide (dicetel) has demonstrated its high efficacy. Biofeedback therapy or surgical techniques may be used. There is a need to prescribe laxatives in any type of constipation. A pathogenetic approach to treating constipation is most efficient. The paper characterizes stimulant, osmotic, volume, and emollient laxatives and agents stimulating the urge to defecate. It also gives the data of meta-analyses evaluating the efficacy of different drug groups. Particular emphasis is laid of the effect of lactulose and its first preparation - duphalac.

About the authors

E V Luzina

ГБОУ ВПО "Читинская государственная медицинская академия"

Email: el.luz@list.ru

References

  1. Парфенов А.И. Три варианта патогенеза и терапии хронического запора. Экспер и клин гастроэнтерол 2012; 3: 7-19.
  2. Tarig S.H. Constipation in Long-Term Care. J Am Med Dir Assoc 2007; 8: 209-218.
  3. Pohl D., Tutuian R., Fried M. Pharmacologic treatment of constipation: what is new? Curr Opin Pharmacol 2008; 8 (6): 724-728.
  4. Белоусова Е.А., Никулина И.В. Принципы выбора слабительных средств у разных категорий больных запором. Фарматека 2009; 2: 48-53.
  5. Drossman D.A. The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology 2006; 130 (5): 1377-1390.
  6. Ault A. Zelnorm pulled off the shelf due to possible cardiovascular risk signal. Family Practice News 2007.
  7. Camilleri M., Van Outryve M.J., Beyens G. et al. Clinical trial: The efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. Aliment Pharmacol Ther 2010; 32: 1113-1123.
  8. Ford A.C., Suares N.C. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 2011; 60 (2): 209-218.
  9. Маев И.В., Вьючнова Е.С., Лебедева Е.Г. и др. Хронический запор, подходы к постановке диагноза и лечению Фарматека 2011; 12: 74-79.
  10. Wilkins T., Pepitone C., Alex B., Schade R.R. Diagnosis and Management of IBS in Adults. Am Fam Physician 2012; 86 (5): 419-426.
  11. Poynard T., Regimbeau C., Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001; 15: 355-361.
  12. Белоусова Е.А., Никитина Н.В., Мишуровская Т.С., Черногорова М.В. Пинаверия бромид (Дицетел) при синдроме раздраженного кишечника. Фарматека 2010; 15: 105-108.
  13. Han E.C., Oh H.K., Ha H.K. et al. Favorable surgical treatment outcomes for chronic constipation with features of colonic pseudoobstuction. World J Gastroenterol 2012; 18 (32): 4441-4446.
  14. Rao S.S., Seaton K., Miller M. et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol 2007; 5: 331-338.
  15. Tack J., Muller-Lissner S. Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol 2009; 7 (5): 502-508.
  16. Mueller-Lissner S., Kamm M.A., Wald A. et al. Multicenter 4-week double-blind randomized placebo-controlled trial of sodium picosulfate in patients with chronic constipation. Am J Gastroenterol 2010; 105: 897-903.
  17. Bruckert E., Rosenbaum D. Lowering LDL-cholesterol through diet: Potential role in the statin era. Curr Opin Lipidol 2011; 22: 43-48.
  18. Pare P. The approach to diagnosis and treatment of chronic constipation: Suggestions for a general practitioner. Can J Gastroenterol 2011; (Suppl B): 36B-40B.
  19. Полуэктова Е.А., Кучумова С.Ю., Шептулин А.А., Ивашкин В.Т. Лечение синдрома раздраженного кишечника с позиций современных представлений о патогенезе заболевания. РЖГГК 2013; 1: 57-65.
  20. Liu L.W.C. Chronic constipation: Current treatment options. Can J Gastroenterol 2011; 25 (Suppl B): 22B-28B.
  21. Сhen X., Zhai X., Kang Z., Sun X. Lactulose: an effective preventive and therapeutic option for ischemic stroke by production of hydrogen. Med Gas Res 2012; 2: 3.
  22. Ерофеев Н.П., Радченко В.Г., Селиверстов П.В. Клиническая физиология толстой кишки. Механизмы действия короткоцепочечных жирных кислот а норме и при патологии. Ст-Петербург: Форте Принт 2012.
  23. Panesar P.S., Kumari S. Lactulose: production, purification and potential applications. Biotechnol Adv 2011; 29 (6): 940-948.
  24. Pare P., Bridges R., Champion M.C. et al. Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol 2007; 21 (Suppl B): 3B-22B.
  25. Boisson J. Trial with duphalac (lactulose) for the withdrawal of irritant laxatives. Results of a double-blind, multicentre clinical trial involving patients whose irritant laxatives were withdrawn overmight. Le Concours Medical 1991; 1-12.
  26. Chmielewska A., Szajewska H. Systematic review of randomized controlled trials: Probiotics for functional constipation. World J Gastroenterol 2010; 16: 69-75.
  27. Li S.R., Wang H.H., Wu Z.Y. et al. Efficacies of lactulose plus live combined Bacillus Subtilis and Enterococcus Faecium Capsules in the treatment of functional constipation: a multicenter, randomized, double blind, controlled trial. Zhonghua Yi Xue Za Zhi 2012; 92 (42): 2955-2960.

Copyright (c) 2014 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies